	La Marge Brute Sur Les Ventes		Date
Alaunos Therapeutics	USD -1.13M	1.11M	2024-09
Alnylam Pharmaceuticals	USD 829.31M	219.56M	2025-12
Amgen	USD 6.48B	307M	2025-09
Bayer	EUR 5.35B	1.02B	2025-09
BioCryst Pharmaceuticals	USD -88.88M	202.74M	2024-12
Biogen	USD 1.65B	34.6M	2025-12
BioMarin Pharmaceutical	USD 713.01M	81.81M	2025-12
Cipla	INR 41.64B	6.31B	2025-12
Clal Biotechnology	ILS -857K	1.42M	2022-06
Compugen	USD 241K	649K	2025-09
CSL	USD 4.46B	2.71B	2025-12
Gilead Sciences	USD 6.31B	106M	2025-12
GlaxoSmithKline	GBP 6.18B	106M	2025-12
Grifols	EUR 766.49M	39.74M	2024-12
Ionis Pharmaceuticals	USD 195M	40M	2025-12
J&J	USD 16.6B	118M	2025-12
Karyopharm Therapeutics	USD -30.78M	1.29M	2024-12
Merck	USD 13.42B	431M	2025-09
Novartis	USD 10.82B	695M	2025-09
Omeros	USD -33.16M	18.52M	2024-06
Pfizer	USD 3.54B	7.61B	2025-09
Roche Holding	CHF 22.09B	10.04B	2025-12
Sangamo BioSciences	-2.39M	1.09M	2024-06
Sanofi	EUR 8.45B	1.31B	2025-12
Sarepta Therapeutics	USD 43.55M	204.36M	2025-12
Tectonic Therapeutic	USD 0	0	2025-03
Ultragenyx Pharmaceutical	USD 178M	46.06M	2025-12
Vertex Pharmaceuticals	USD 2.72B	62.4M	2025-12

Sangamo BioSciences La Marge Brute Sur Les Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.